Peter MacCallum Cancer Centre will today officially open a world-leading Centre of Excellence to accelerate research and development of next-generation targeted treatments for prostate cancer.
Research underway at Peter Mac to help protect cancer patients from COVID-19 has received a $2.16 million boost from the Federal Government's Medical Research Future Fund.
Overall survival from ovarian cancer has not improved for several decades. Now, a Peter Mac-led team of scientists have discovered a new approach to tackling this disease, by raising the stress levels inside cancer cells.
Twelve Peter Mac researchers have been awarded Investigator Grant funding from the National Health and Medical Research Council (NHMRC) to support discovery-based studies on cancer development and research into improved cancer detection and prognosis, and more precise cancer treatments.
Activating two different types of immune cells at the same time has been shown to boost the effects of immunotherapy to find and kill cancer cells in solid tumours.
Peter Mac researchers have been awarded a four year grant from the Federal Government’s Medical Research Future Fund to investigate new combination therapies for a rare form of ovarian cancer.
Peter Mac's A/Prof Kate Burbury, Haematologist and Deputy Chief Medical Officer, talks to Sabre Lane on ABC's AM about the expansion of Telehealth during COVID-19 and the massive benefits to patients.